Global Market For Dairy Bioactives Growing By Close To 10% Annually, New Report Says
Aarhus C, Denmark—There is clearly increasing activity within the dairy-derived bioactives market, according to a new report from 3A Business Consulting.
The dairy bioactives product range continues to expand, more patents are being issued, the number of new consumer products launched containing these bioactives is continuously increasing, and the current market size, estimated at more than 55,000 metric tons (121 million pounds) with approximate value of US$1 billion, is growing by close to 10 percent per annum, said the report, entitled The World Market for Dairy Bioactives 2015-2019.
“The dairy bioactives business is a high tech, high risk and potentially a high reward business, as it takes considerable knowledge and resources in processing technologies, regulatory aspects including claims and marketing capability to be successful,” commented Tage Affertsholt, managing partner of 3A Business Consulting.
The market for dairy bioactivies is being driven by the broader nutrition industry, i.e., infant formula, sports nutrition, dietary supplements, clinical nutrition and functional foods, the report said.
The major players are the large dairy ingredient companies with significant technological depth and global market research, such as Arla Foods Ingredients, FrieslandCampina, Agropur/Davisco, Glanbia, Fonterra, Ingredia, Murray Goulburn, Carbery, Armor Proteines, Morinaga/Milei and others, according to the report.
The New Zealand-based Tatau is an example of a small player having created a global niche position within bioactives, the report noted. Relatively new players within this area are some US-based companies such as Hilmar Ingredients and Milk Specialties Global.
The report is global in scope and covers a wide range of ingredients such as milk and whey hydrolysates, peptides, glycomacropeptides, caseinphosphopeptides, alpha-lactalbumin, beta-lactoglobulin, immunoglobulins, lactoferrin, osteopontin, milk phospholipids, galactooligosaccharides (GOS), and more.
Report headlines include: market size (volume and value) and expected growth; current applications and new product development trends; historical and current price developments; producer profiles; application and breakdown of end-use segments; drivers and barriers; regulatory issues; and patent activity within the given product areas.
“Generally, bioactives addressing the current key health issues have excellent growth opportunities, and dairy-derived bioactives will be part of the solution in the future,” Affertsholt said.
The report can be purchased for 4,700.00 euros.
For more information, contact Tage Affertsholt, 3A Business Consulting, at firstname.lastname@example.org; or visit www.3abc.dk.